Leading ministers seek EU drug regulation deal

Two cabinet ministers have suggested that the UK will continue to co-operate with the EU on medicine testing after Brexit.

Despite fears that fears Brexit may cause delays in UK patients getting new drugs, Health Secretary Jeremy Hunt and Business Secretary Greg Clark have acknowledged the risks associated with regulation and trade, but have said that the ‘UK would like to find a way to continue to collaborate with the EU’.

Writing in the Financial Times, the ministers said that the priority is to ‘ensure that patients in the UK and across the EU continue to be able to access the best and most innovative medicines’.

Citing examples of UK-EU collaboration, the ministers wrote that the UK ‘will look to continue to work closely with the European Medicines Agency’, but also said that is the ‘desired’ deal is not possible, then the country would look to ‘set up a regulatory system’ to process drugs licences ‘as quickly as possible’.

Mike Thompson, chief executive of the Association of the British Pharmaceutical Industry, labelled the ministers' letter as ‘a welcome recognition that the future of medicines regulation is a key priority for the government’.

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho